Page 68 - Read Online

Page 8 of 9 Kawakibi et al. Plast Aesthet Res 2023;10:48 https://dx.doi.org/10.20517/2347-9264.2022.120

cutting edge of clinical application. Front Cell Dev Biol 2020;8:236. DOI PubMed PMC
32. Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory
capacity than their bone marrow-derived counterparts. Stem Cells Transl Med 2013;2:455-63. DOI PubMed PMC
33. Montespan F, Deschaseaux F, Sensébé L, Carosella ED, Rouas-Freiss N. Osteodifferentiated mesenchymal stem cells from bone
marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in
bone repair therapy. J Immunol Res 2014;2014:230346. DOI PubMed PMC
34. Soleymaninejadian E, Pramanik K, Samadian E. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am
J Reprod Immunol 2012;67:1-8. DOI PubMed
35. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus
bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 2012;21:2724-52. DOI PubMed
36. Min CK, Kim BG, Park G, Cho B, Oh IH. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute
graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant 2007;39:637-45. DOI
PubMed
37. Amos PJ, Kapur SK, Stapor PC, et al. Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell
formulation and delivery. Tissue Eng Part A 2010;16:1595-606. DOI PubMed PMC
38. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal
stem cells. Nat Med 2005;11:367-8. DOI
39. Merfeld-Clauss S, Gollahalli N, March KL, Traktuev DO. Adipose tissue progenitor cells directly interact with endothelial cells to
induce vascular network formation. Tissue Eng Part A 2010;16:2953-66. DOI PubMed PMC
40. Wang L, Hu L, Zhou X, et al. Author Correction: exosomes secreted by human adipose mesenchymal stem cells promote scarless
cutaneous repair by regulating extracellular matrix remodelling. Sci Rep 2021;11:3245. DOI PubMed PMC
41. Marten TJ, Elyassnia D. Fat grafting in facial rejuvenation. Clin Plast Surg 2015;42:219-52. DOI PubMed
42. Coleman SR. Structural fat grafting. Aesthet Surg J 1998;18:386-8. DOI PubMed
43. Blezien O, D'Andrea F, Nicoletti GF, Ferraro GA. Effects of fat grafting containing stem cells in microstomia and microcheilia derived
from systemic sclerosis. Aesthetic Plast Surg 2017;41:839-44. DOI PubMed
44. Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous manifestations of scleroderma and scleroderma-like
disorders: a comprehensive review. Clin Rev Allergy Immunol 2017;53:306-36. DOI PubMed
45. Jaeger VK, Wirz EG, Allanore Y, et al; EUSTAR co-authors. Incidences and risk factors of organ manifestations in the early course of
systemic sclerosis: a longitudinal EUSTAR study. PLoS One 2016;11:e0163894. DOI PubMed PMC
46. Bajraktari IH, Kryeziu A, Sherifi F, Bajraktari H, Lahu A, Bajraktari G. Oral manifestations of systemic sclerosis and correlation with
anti-topoisomerase I antibodies (SCL-70). Med Arch 2015;69:153-6. PubMed PMC
47. Maddali Bongi S, Del Rosso A, Galluccio F, et al. Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp
Rheumatol 2009;27(3 Suppl 54):44-50. PubMed
48. Gheisari M, Ahmadzadeh A, Nobari N, Iranmanesh B, Mozafari N. Autologous fat grafting in the treatment of facial scleroderma.
Dermatol Res Pract 2018;2018:6568016. DOI PubMed PMC
49. Del Papa N, Caviggioli F, Sambataro D, et al. Autologous fat grafting in the treatment of fibrotic perioral changes in patients with
systemic sclerosis. Cell Transplant 2015;24:63-72. DOI
50. Yang Z, Jin S, He Y, Zhang X, Han X, Li F. Comparison of microfat, nanofat, and extracellular matrix/stromal vascular fraction gel
for skin rejuvenation: basic research and clinical applications. Aesthet Surg J 2021;41:NP1557-70. DOI
51. Nguyen PS, Desouches C, Gay AM, Hautier A, Magalon G. Development of micro-injection as an innovative autologous fat graft
technique: the use of adipose tissue as dermal filler. J Plast Reconstr Aesthet Surg 2012;65:1692-9. DOI PubMed
52. Sautereau N, Daumas A, Truillet R, et al. Efficacy of autologous microfat graft on facial handicap in systemic sclerosis patients. Plast
Reconstr Surg Glob Open 2016;4:e660. DOI PubMed PMC
53. Alharbi Z, Opländer C, Almakadi S, Fritz A, Vogt M, Pallua N. Conventional vs. micro-fat harvesting: how fat harvesting technique
affects tissue-engineering approaches using adipose tissue-derived stem/stromal cells. J Plast Reconstr Aesthet Surg 2013;66:1271-8.
DOI
54. Magalon G, Daumas A, Sautereau N, Magalon J, Sabatier F, Granel B. Regenerative approach to scleroderma with fat grafting. Clin
Plast Surg 2015;42:353-64, viii-ix. DOI PubMed
55. Virzì F, Bianca P, Giammona A, et al. Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial
skin-induced lesion regeneration for scleroderma patients. Stem Cell Res Ther 2017;8:236. DOI PubMed PMC
56. Willemsen JC, van der Lei B, Vermeulen KM, Stevens HP. The effects of platelet-rich plasma on recovery time and aesthetic outcome
in facial rejuvenation: preliminary retrospective observations. Aesthetic Plast Surg 2014;38:1057-63. DOI PubMed
57. Maeda M, Matubara K, Hirano H, Watabe H, Ichiki Y, Mori S. Pitting scars in progressive systemic sclerosis. Dermatology
1993;187:104-8. DOI PubMed
58. Bene MD, Pozzi MR, Rovati L, Mazzola I, Erba G, Bonomi S. Autologous fat grafting for scleroderma-induced digital ulcers. An
effective technique in patients with systemic sclerosis. Handchir Mikrochir Plast Chir 2014;46:242-7. DOI PubMed
59. McMahan ZH, Wigley FM. Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and
management. Int J Clin Rheumtol 2010;5:355-70. PubMed PMC
60. Hachulla E, Clerson P, Launay D, et al. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective